EGF receptor inhibitors comprehensively suppress hepatitis B virus by downregulation of STAT3 phosphorylation

Current antiviral therapy can not cure chronic hepatitis B virus (HBV) infection or eliminate the risk of hepatocellular carcinoma. The licensed epidermal growth factor receptor (EGFR) inhibitors have found to inhibit hepatitis C virus replication via downregulation of signal transducers and activat...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Biochem Biophys Rep
Main Authors: Gan, Chong J., Li, Wen F., Li, Chun N., Li, Ling L., Zhou, Wen Y., Peng, Xiao M.
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2020
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7170955/
https://ncbi.nlm.nih.gov/pubmed/32322693
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbrep.2020.100763
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados